DiagnaMed’s BRAIN AGE Brain Health AI Platform Targeting Multi-Billion Digital Brain Health Market

TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is commercializing its novel BRAIN AGE Brain Health AI Platform (“BRAIN AGE”), a world-first consumer brain health and wellness AI solution that estimates brain age and provides a brain health score, targeting the global digital brain health market projected to be USD 405.53 billion by 2031.¹

Fabio Chianelli, CEO of DiagnaMed, commented: “We are entering into our next growth phase through the commercialization of our novel BRAIN AGE Brain Health AI Platform that empowers individuals and healthcare professionals seeking to improve overall brain health. After several years of research and development, along with clinical studies validating the potential utility of our BRAIN AGE Brain Health AI Platform, we are now focused on executing our commercialization plan by educating medical communities about the potential of BRAIN AGE and its value proposition to motivated individuals wanting to take control of their brain health and to a network of healthcare clinics as a service to their clients.”

Opportunity of BRAIN AGE Brain Health AI Platform

According to ECON Market Research, the global digital brain health market is a rapidly growing sector that aims to use technology to improve brain function, prevent cognitive decline, and manage neurological disorders and was valued at USD 199.98 billion in 2022 and projected to be USD 405.53 billion by 2031.¹ Based on research studies at Drexel University and the University of Miami, BRAIN AGE Brain Health AI aims to ‘raise a red flag’ for potential brain health issues. BRAIN AGE Brain Health AI can assess if a brain is aging more quickly or more slowly than is typical for healthy individuals. Brain age is estimated by collecting neural activity data of the brain with a low-cost and easy-to-use electroencephalogram headset and calculating the data with a proprietary machine-learning model. In addition, BRAIN AGE Brain Health AI can assess if a person has a healthy brain or is in the early stage of cognitive decline. Brain health is scored by taking a clinically validated assessment for brain resilience, vulnerability and performance functions. Individuals can seek out personalized diagnostics and interventions, such as medication or lifestyle changes, that may help to decrease the development or progression of cognitive decline.